Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ACM, BAVA get smallpox contracts

As expected, the NIH's National Institute of Allergy and Infectious Diseases awarded two smallpox Modified Vaccinia Ankara (MVA) vaccine contracts to Acambis

Read the full 229 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE